Shanghai HeartCare Proposes New Articles to Align With Paperless Listing Rules

Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has shared an update.

Shanghai HeartCare Medical Technology Corporation Limited has proposed amendments to its articles of association to align with updated regulatory requirements, particularly those related to the further expansion of Hong Kong’s paperless listing regime. The move includes adopting an entirely new set of articles to replace the current version, signaling an administrative modernization of its corporate framework.

The proposed changes, which also incorporate general housekeeping updates, are subject to approval by shareholders via a special resolution at the forthcoming annual general meeting. The company plans to circulate detailed documentation of the amendments along with the AGM notice in due course, giving investors formal opportunity to review and vote on the corporate governance adjustments.

More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H

Shanghai HeartCare Medical Technology Corporation Limited is a PRC-incorporated medical technology company listed in Hong Kong, focusing on cardiovascular-related medical devices and solutions. The company operates under stock code 6609 and is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical Hong Kong-listed corporate governance structure.

Average Trading Volume: 60,114

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$2.18B

For detailed information about 6609 stock, go to TipRanks’ Stock Analysis page.